TrialVaccine2018

Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.

Vladimir Gilca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.